What is DSS Inc?
operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States.
DSS · Verdict
Limited reward · high risk
DSS has limited near-term tailwinds — profitability and balance sheet weigh on the model output.
Based on 88% data coverage
DSS · Verdict
-246% net margin · -100% ROE
Current ratio 0.98
-48% free-cash-flow margin
Rev -2.0% CAGR · earnings +12.3%
Below average
Model-based scoring. For information only — not financial advice.
operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company is listed on the NYSE MKT in USA, operating in the Consumer Cyclical sector, with a market capitalisation of 9.24M.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.